ID

36569

Beschreibung

Phase II Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN); ODM derived from: https://clinicaltrials.gov/show/NCT01953055

Link

https://clinicaltrials.gov/show/NCT01953055

Stichworte

Versionen (2)
  1. 17.01.19 17.01.19 -
  2. 22.05.19 22.05.19 -
Rechteinhaber

Sunnybrook Health Sciences Centre

Hochgeladen am

22. Mai 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

SABR in High Risk Prostate Cancer (SATURN) NCT01953055

Englisch

Eligibility Criteria

1 Formulare  
  1. StudyEvent: Eligibility
    1. Eligibility Criteria
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
informed consent obtained
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
men > 18 years of age
Beschreibung

Age and Gender

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
histologically confirmed prostate adenocarcinoma (centrally reviewed)
Beschreibung

histologically confirmed prostate adenocarcinoma (centrally reviewed)

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0679557
UMLS CUI [1,2]
C0007112
high risk prostate cancer, defined as at least one of clinical stage T3 or Gleason 8-10, or PSA > 20ng/ml
Beschreibung

prostate cancer risk assessment, by clinical T stage, Gleason Score, or PSA

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0086930
UMLS CUI [2]
C3258246
UMLS CUI [3]
C0332326
UMLS CUI [4]
C0138741
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior pelvic radiotherapy
Beschreibung

prior pelvic radiotherapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C1536155
anticoagulation medication (if unsafe to discontinue for gold seed insertion)
Beschreibung

anticoagulation medication (if unsafe to discontinue for gold seed insertion)

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003280
UMLS CUI [1,2]
C1548265
UMLS CUI [2]
C4040254
diagnosis of bleeding diathesis
Beschreibung

bleeding diathesis

Datentyp

boolean

Alias
UMLS CUI [1]
C0005779
large prostate (>90cm³) on imaging at time of gold seed insertion
Beschreibung

prostate size on imaging at seed insertion

Datentyp

boolean

Alias
UMLS CUI [1]
C1287816
UMLS CUI [2,1]
C2348792
UMLS CUI [2,2]
C4040254
no evidence of castrate resistance (defined as psa < 3ng/ml while testosterone is < 0.7nmol/l)
Beschreibung

no evidence of castrate resistance (defined by PSA and testosterone)

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C4270759
UMLS CUI [2]
C0201544
UMLS CUI [3]
C0428413
definitive regional or distant metastatic disease on staging investigations
Beschreibung

definitive regional or distant metastatic disease on staging investigations

Datentyp

boolean

Alias
UMLS CUI [1]
C1275402
UMLS CUI [2,1]
C0205147
UMLS CUI [2,2]
C0027627
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Criteria

1 Formulare
  1. StudyEvent: Eligibility
    1. Eligibility Criteria
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
informed consent
Item
informed consent obtained
boolean
C0021430 (UMLS CUI [1])
Age and Gender
Item
men > 18 years of age
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
histologically confirmed prostate adenocarcinoma (centrally reviewed)
Item
histologically confirmed prostate adenocarcinoma (centrally reviewed)
boolean
C0679557 (UMLS CUI [1,1])
C0007112 (UMLS CUI [1,2])
prostate cancer risk assessment, by clinical T stage, Gleason Score, or PSA
Item
high risk prostate cancer, defined as at least one of clinical stage T3 or Gleason 8-10, or PSA > 20ng/ml
boolean
C0600139 (UMLS CUI [1,1])
C0086930 (UMLS CUI [1,2])
C3258246 (UMLS CUI [2])
C0332326 (UMLS CUI [3])
C0138741 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
prior pelvic radiotherapy
Item
prior pelvic radiotherapy
boolean
C1514463 (UMLS CUI [1,1])
C1536155 (UMLS CUI [1,2])
anticoagulation medication (if unsafe to discontinue for gold seed insertion)
Item
anticoagulation medication (if unsafe to discontinue for gold seed insertion)
boolean
C0003280 (UMLS CUI [1,1])
C1548265 (UMLS CUI [1,2])
C4040254 (UMLS CUI [2])
bleeding diathesis
Item
diagnosis of bleeding diathesis
boolean
C0005779 (UMLS CUI [1])
prostate size on imaging at seed insertion
Item
large prostate (>90cm³) on imaging at time of gold seed insertion
boolean
C1287816 (UMLS CUI [1])
C2348792 (UMLS CUI [2,1])
C4040254 (UMLS CUI [2,2])
no evidence of castrate resistance (defined by PSA and testosterone)
Item
no evidence of castrate resistance (defined as psa < 3ng/ml while testosterone is < 0.7nmol/l)
boolean
C0332197 (UMLS CUI [1,1])
C4270759 (UMLS CUI [1,2])
C0201544 (UMLS CUI [2])
C0428413 (UMLS CUI [3])
definitive regional or distant metastatic disease on staging investigations
Item
definitive regional or distant metastatic disease on staging investigations
boolean
C1275402 (UMLS CUI [1])
C0205147 (UMLS CUI [2,1])
C0027627 (UMLS CUI [2,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video